News for hackers. Stuff that matters.

cacioepepe

Re:Ask HN: How Are Life Extension Efforts Going? on Tuesday January 25, 2022 @10:44AM (#30073070)
I would hope so.

I used to think this was sort of the domain of crackpot billionaires faced with the fear of their own unavoidable death, the ultimate obstacle for them personally.

It may be, but with demographic trends I see it as more of a urgent public health issue. The inverted pyramid starting to show up in many places means we either have to increase the population of young, or somehow increase the health of older individuals into older ages. Both are probably necessary but the former often implies an increasing population size as a whole, which has its own consequences (it doesn't have to be that way but often is).

I just saw a couple of articles somewhere about investments in a major research institute, where they were luring people away from academic positions? So it seems at least nominally there still is ongoing investment in the area.

My impression is that so far it seems to be progressing like most areas of science: there seem to be a couple of well-established findings (like caloric restriction), along with a steady rate of new findings that usually don't replicate or generalize.

The most recent interest I've read about has been in senolytic compounds like fisetin and quercetin-dasatinib mixtures. It's unclear to me how that is working out one way or the other. It seems promising but also without a lot of data yet. If I remember correctly there were some concerns about ongoing use of low-dose dasatinib in some people but I might be misremembering that.

My sense is this area is somewhat difficult because it has had the reputation of "searching for a fountain of youth" and being the domain of aging billionaires. It also requires time in humans, which is notoriously difficult in research for practical reasons.

Also, a lot of it falls into this area that is medically regulated, but outside the domain of traditional clinical practice. This creates a problem because it's not treated as a disease that could be leveraged for clinical research. E.g., you can't apply the model of "randomize treatments to people who would be coming into the clinic anyway for disease X" because it's not recognized as a disease. But if it's something like quercetin-dasatinib compound, you can't just get it as a supplement, and so study it that way.

Hopefully the stigma issue will decline; the longitudinal issue is more challenging in some ways. The issue about it being regulated but not a disease is more problematic, and will either require a change in mindset (maybe going along with the stigma issue) and/or will require some deregulation of healthcare.

In the supplement what's buried is that there were no effects on measured cognitive development in the overall sample.

Meaning that in the subsample of parents who received cash disbursements and did EEG, they found differences in EEG, but that the outcome of importance -- cognitive performance -- did not differ.

Also, as far as I can tell, the EEG measures did not relate to cognitive performance, which calls into question the validity of the EEG measures as markers of what matters.

So, two things:

Even when you preregister things, you can cherrypick your findings if you're allowed to write it up that way by the editor and reviewers. In some ways this paper is like a window into what might have happened if their results weren't preregistered.

It raises the question of whether or not these neural measures are really of value, as they don't predict the thing of importance.

I'm very in favor of financial assistance to people in poverty (and even those who are more resourced) but this study was poorly done (or at least poorly reported) and does a disservice to those advocating for the importance of social safety nets.

Re:Get ahead by not shooting yourself in the foot on Monday January 24, 2022 @03:53PM (#30063878)
The tricky part, as it was for me, was when things change. Things can be great somewhere, and then something at very high levels cause trickledown, and before you know it, minor problems turn into complete institutional dysfunction. It's like the butterfly effect, but with organizational dysfunction.

Add your spouse having other constraints, and it becomes a mess to navigate sometimes.